BMS may have been absent from the…
BMS may have been absent from the dealmaking spree of [...]
Attovia Therapeutics, Braveheart…
Attovia Therapeutics, Braveheart Bio and Vogenx have set target ranges [...]
The FDA has rebuked Viatris for a…
The FDA has rebuked Viatris for a direct-to-consumer video that [...]
Sanofi’s new CEO Belén Garijo…
Sanofi’s new CEO Belén Garijo opened up for the first [...]
Johnson & Johnson is cruising…
Johnson & Johnson is cruising deeper into in vivo CAR-T [...]
A panel of experts today voted…
A panel of experts today voted against Capricor’s cell therapy [...]
Eli Lilly has doubled down on its…
Eli Lilly has doubled down on its partnership with CDMO [...]
With increased sales of its newer…
With increased sales of its newer drugs compensating for declining [...]
AbCellera’s T-cell engager…
AbCellera’s T-cell engager platform has reeled in a second client [...]
The U.K. pharma marketing watchdog…
The U.K. pharma marketing watchdog has slammed AGB Pharma for [...]